NASDAQ:AKTS - Akoustis Technologies Stock Price, Forecast & News

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Akoustis Technologies Inc (NASDAQ:AKTS) announced its quarterly earnings results on Monday, February, 3rd. The technology company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.04. The technology company had revenue of $0.52 million for the quarter, compared to the consensus estimate of $0.55 million. View Akoustis Technologies' Earnings History.

Akoustis Technologies is scheduled to release their next quarterly earnings announcement on Friday, May 8th 2020. View Earnings Estimates for Akoustis Technologies.

4 equities research analysts have issued 12 month price objectives for Akoustis Technologies' shares. Their forecasts range from $7.00 to $12.00. On average, they expect Akoustis Technologies' share price to reach $10.00 in the next twelve months. This suggests a possible upside of 27.9% from the stock's current price. View Analyst Price Targets for Akoustis Technologies.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Akoustis Technologies.

News coverage about AKTS stock has trended neutral on Sunday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Akoustis Technologies earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Akoustis Technologies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include NVIDIA (NVDA), Verizon Communications (VZ), Alibaba Group (BABA), Canopy Growth (CGC), Crispr Therapeutics (CRSP), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Marvell Technology Group (MRVL), InVitae (NVTA) and QUALCOMM (QCOM).

Akoustis Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Silverback Asset Management LLC (3.05%), Senvest Management LLC (1.33%), State Street Corp (1.18%), Essex Investment Management Co. LLC (0.95%), UBS Group AG (0.89%) and Perkins Capital Management Inc. (0.56%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, John T Kurtzweil, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy. View Institutional Ownership Trends for Akoustis Technologies.

AKTS stock was sold by a variety of institutional investors in the last quarter, including Financial Advocates Investment Management, Benjamin F. Edwards & Company Inc., New York State Common Retirement Fund, Mercer Global Advisors Inc. ADV, Raymond James Financial Services Advisors Inc. and Bank of America Corp DE. Company insiders that have sold Akoustis Technologies company stock in the last year include David Aichele, Jeffrey B Shealy, Kenneth Boller, Rohan Houlden and Steven Denbaars. View Insider Buying and Selling for Akoustis Technologies.

AKTS stock was purchased by a variety of institutional investors in the last quarter, including Silverback Asset Management LLC, Senvest Management LLC, Taylor Frigon Capital Management LLC, Penn Capital Management Co. Inc., Perkins Capital Management Inc., Granite Point Capital Management L.P., Essex Investment Management Co. LLC and Eidelman Virant Capital. View Insider Buying and Selling for Akoustis Technologies.

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AKTS stock can currently be purchased for approximately $7.82.